FRONTIER CAPITAL MANAGEMENT CO LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5,855,723
-30.2%
127,326
-12.7%
0.06%
-20.0%
Q2 2023$8,384,643
+19.5%
145,896
-22.0%
0.08%
+9.6%
Q1 2023$7,014,750
+22.7%
187,060
-8.3%
0.07%
+17.7%
Q4 2022$5,715,267
-0.6%
203,971
-0.3%
0.06%
-7.5%
Q3 2022$5,749,000
-19.7%
204,573
-0.5%
0.07%
-18.3%
Q2 2022$7,155,000
-20.7%
205,663
-18.2%
0.08%0.0%
Q1 2022$9,021,000
+53.6%
251,272
-0.4%
0.08%
+78.3%
Q4 2021$5,874,000
+20.8%
252,208
-1.4%
0.05%
+21.1%
Q3 2021$4,863,000
+30.4%
255,813
+38.3%
0.04%
+40.7%
Q2 2021$3,729,000184,9790.03%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders